Results 191 to 200 of about 27,059 (274)

How the Fibrotic Lung Microenvironment Regulates Stem Cell Behavior: Immune Cues, Extracellular Matrix Remodeling, and Therapeutic Implications

open access: yesAnalytical Cellular Pathology, Volume 2026, Issue 1, 2026.
Pulmonary fibrosis (PF) is a chronic and progressive interstitial lung disease characterized by excessive extracellular matrix (ECM) deposition and remodeling of lung structures. Currently, no effective clinical treatments exist to reverse or halt the progression of PF.
Zihan Zhou   +5 more
wiley   +1 more source

Exploring the Link Between PACAP Signalling and Hyaluronic Acid Production in Melanoma Progression. [PDF]

open access: yesInt J Mol Sci
Hajdú T   +10 more
europepmc   +1 more source

Small hyaluronan oligosaccharides induce inflammation by engaging both toll-like-4 and CD44 receptors in human chondrocytes

open access: green, 2010
Giuseppe M. Campo   +5 more
openalex   +2 more sources

Heterogeneity and Therapeutic Potential of Programmed Cell Death Pathways in STMN1+ EPCs in Cutaneous T‐Cell Lymphoma

open access: yesInternational Journal of Clinical Practice, Volume 2026, Issue 1, 2026.
Background Primary cutaneous T‐cell lymphomas (CTCLs) are a heterogeneous group of T‐cell lymphomas that begin with skin manifestations. In advanced mycosis fungoides (MF), as MF reached advanced stages, the lesions disseminated beyond the skin, involving lymph nodes and blood, which further worsened the prognosis.
Huan Yao   +6 more
wiley   +1 more source

N-glycosylation blocks and fosters different receptor-ligand binding sites: the chameleonic CD44–hyaluronan interaction - simulation set B3

open access: green, 2020
Joni Vuorio   +6 more
openalex   +2 more sources

Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future

open access: yesCA: A Cancer Journal for Clinicians, Volume 76, Issue 1, January/February 2026.
Abstract Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a dismal prognosis, largely because of late‐stage diagnosis and therapeutic resistance. PDAC incidence has been rising, with modifiable and non‐modifiable risk factors contributing to disease development.
Alessandro Mannucci, Ajay Goel
wiley   +1 more source

Definition, Epidemiology and Pathophysiology of Lymphoedema. [PDF]

open access: yesCells
Brenner E   +4 more
europepmc   +1 more source

LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan [PDF]

open access: bronze, 1999
Suneale Banerji   +7 more
openalex   +1 more source

Home - About - Disclaimer - Privacy